Given SB now have 19.99% of the company any more shares at all would take them over 20 per cent you would think.
The company has clearly stated that SB get's an entitlement, but that it is NOT part of the $6m they are seeking.
I don't think they will get the $6m.
- Forums
- ASX - By Stock
- Ann: Appendix 3B - Star Bright Placement Issue
Given SB now have 19.99% of the company any more shares at all...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.65 |
Change
-0.350(2.92%) |
Mkt cap ! $246.2M |
Open | High | Low | Value | Volume |
$11.57 | $11.81 | $11.52 | $67.41K | 5.775K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 510 | $11.56 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.66 | 160 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 810 | 11.510 |
2 | 1092 | 11.500 |
1 | 201 | 11.410 |
1 | 697 | 11.390 |
1 | 11000 | 11.350 |
Price($) | Vol. | No. |
---|---|---|
11.660 | 160 | 2 |
11.890 | 190 | 2 |
11.900 | 1000 | 1 |
12.000 | 4817 | 1 |
12.370 | 231 | 1 |
Last trade - 13.15pm 10/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
AVR (ASX) Chart |
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
SPONSORED BY The Market Online